Genenta Science S.p.A.
GNTANASDAQHealthcare● Active
$1.80
+$0.00(+0.13%)
Market Cap$34507679
P/E Ratio—
52W High$10
52W Low$0.55
Genenta Science S.p.A. (GNTA) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
GNTA · earnings · updated Jun 9, 2026
Latest Earnings
Q1 FY2026Report Date: Mar 31, 2026EPS Actual
-$0.36
Est. -$0.36 · +0.0%
Revenue
—
Fiscal Period
Q1 FY2026
FY ends December
Report Date
Mar 31, 2026
After Market Close
🔥 4-Quarter EPS Beat Streak
GNTA reports quarterly as a NASDAQ-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Sep 2, 2026 | -$0.28 | — | — | — | — | — |
| — Q1 FY2026 | Mar 31, 2026 | -$0.36 | -$0.36 | +0.0% | — | — | — |
| — Q1 FY2026 | Feb 25, 2026 | -$0.36 | -$0.36 | +0.0% | — | — | — |
| ◌ Q1 FY2025 | Mar 28, 2025 | -$0.26 | — | — | — | — | — |
| — Q2 FY2024 | Jun 30, 2024 | — | -$0.24 | — | — | — | — |
| ▲ Q2 FY2024 | Apr 24, 2024 | -$0.42 | -$0.29 | +29.7% | $0.01B | — | — |
| ▲ Q2 FY2023 | Jun 30, 2023 | -$0.41 | -$0.40 | +3.3% | — | — | — |
| — Q2 FY2023 | Apr 26, 2023 | — | -$0.38 | — | — | — | — |
Q3 FY2026
Sep 2, 2026
EPS Actual
—
EPS Est.
-$0.28
EPS Surpr.
—
Revenue
—
Q1 FY2026
Mar 31, 2026
EPS Actual
-$0.36
EPS Est.
-$0.36
EPS Surpr.
+0.0%
Revenue
—
Q1 FY2026
Feb 25, 2026
EPS Actual
-$0.36
EPS Est.
-$0.36
EPS Surpr.
+0.0%
Revenue
—
Q1 FY2025
Mar 28, 2025
EPS Actual
—
EPS Est.
-$0.26
EPS Surpr.
—
Revenue
—
Q2 FY2024
Jun 30, 2024
EPS Actual
-$0.24
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q2 FY2024
Apr 24, 2024Beat
EPS Actual
-$0.29
EPS Est.
-$0.42
EPS Surpr.
+29.7%
Revenue
$0.01B
Q2 FY2023
Jun 30, 2023Beat
EPS Actual
-$0.40
EPS Est.
-$0.41
EPS Surpr.
+3.3%
Revenue
—
Q2 FY2023
Apr 26, 2023
EPS Actual
-$0.38
EPS Est.
—
EPS Surpr.
—
Revenue
—
Analyst Estimates
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2025 | $0.00 | $0.00 | $0.00 | 0 |
| Q3 FY2025 | $0.00 | $0.00 | $0.00 | 0 |
| Q2 FY2025 | $0.00 | $0.00 | $0.00 | 0 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2025 | $0.0B | $0.0B | $0.0B | 0 |
| Q3 FY2025 | $0.0B | $0.0B | $0.0B | 0 |
| Q2 FY2025 | $0.0B | $0.0B | $0.0B | 0 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q1 FY2026 | Mar 31, 2026 | +0.0% | $0.63 | $0.67 | +6.65% |
| ▲ Q1 FY2026 | Feb 25, 2026 | +0.0% | $0.95 | $1.00 | +5.36% |
| — Q2 FY2024 | Jun 30, 2024 | — | $3.10 | $3.08 | -0.65% |
| ▲ Q2 FY2024 | Apr 24, 2024 | +29.7% | $3.63 | $2.55 | -29.75% |
| ▲ Q2 FY2023 | Jun 30, 2023 | +3.3% | $5.90 | $5.89 | -0.17% |
| — Q2 FY2023 | Apr 26, 2023 | — | $6.20 | $6.00 | -3.23% |
| — Q4 FY2022 | Oct 7, 2022 | — | $5.00 | $5.06 | +1.20% |
| — Q2 FY2022 | May 4, 2022 | — | $5.49 | $5.60 | +2.00% |
Q1 FY2026+6.65%
Report Date
Mar 31, 2026
EPS Beat/Miss
+0.0%
Price Before
$0.63
Price After
$0.67
Q1 FY2026+5.36%
Report Date
Feb 25, 2026
EPS Beat/Miss
+0.0%
Price Before
$0.95
Price After
$1.00
Q2 FY2024-0.65%
Report Date
Jun 30, 2024
EPS Beat/Miss
—
Price Before
$3.10
Price After
$3.08
Q2 FY2024-29.75%
Report Date
Apr 24, 2024
EPS Beat/Miss
+29.7%
Price Before
$3.63
Price After
$2.55
Q2 FY2023-0.17%
Report Date
Jun 30, 2023
EPS Beat/Miss
+3.3%
Price Before
$5.90
Price After
$5.89
Q2 FY2023-3.23%
Report Date
Apr 26, 2023
EPS Beat/Miss
—
Price Before
$6.20
Price After
$6.00
Q4 FY2022+1.20%
Report Date
Oct 7, 2022
EPS Beat/Miss
—
Price Before
$5.00
Price After
$5.06
Q2 FY2022+2.00%
Report Date
May 4, 2022
EPS Beat/Miss
—
Price Before
$5.49
Price After
$5.60
Avg Beat Reaction-4.48%
Beat Rate4 / 8 quarters
Largest Move-29.75% (Q2 FY2024)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: GNTA ends December
Genenta Science S.p.A. (GNTA) most recently reported earnings on March 31, 2026 for Q1 FY2026, posting EPS of $-0.36 (in line with the analyst consensus of $-0.36). GNTA has beaten EPS estimates for 4 consecutive quarters. The next GNTA earnings date is expected around September 1, 2026.
Each quarter, investors track GNTA earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. GNTA revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
GNTA's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
GNTA earnings · 4 questionsGenenta Science S.p.A.'s next earnings report is expected around September 1, 2026. GNTA typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; GNTA historically reports after market close (AMC).
GNTA earnings datewhen is GNTA earningsGNTA next earnings datewhen does GNTA report earningsGNTA earnings calendar
▸ Source: FMP · Genenta Science S.p.A. SEC filings · US GAAP · Genenta Science S.p.A. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026